230 Organisation — — «AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview» | Mindmaps

230 Organisation —
AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview
Suggest Organisation

« First Previous Page 20 of 20

AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview

Organisation

Investor

Hub

Industries

aging biomarkers ai company ai for longevity anti-aging therapies application software artificial intelligence, biopharma, biotechnology, early drug development, health care, life science, machine learning, pharmaceutical, software artificial intelligence, biotechnology, early drug development, machine learning, pharmaceutical, quantum computing biomarkers biomarkers discovery biomarkers for personalized medicine biotech & health care biotech & healthtech biotechnology, health care, health diagnostics clinical data management clinical development communication consulting data processing deeptech digital biomarkers drug repurposing early drug development end-to-end drug development femtech functional medicine clinics health tech immunotherapy development industrial management life science experimentation longevity & wellness med tech medical biotech neurodegeneration and aging neurodegenerative disease diagnosis and treatment omics-based biomarkers other pharma tech pharmatech pharmtech preclinical development software technology consulting

© 2024